Type to search

Advent France Biotechnology Launches its Second Fund with a First Close at €86M ($102M) | Pharmtech Focus
New Startup Aglaia Therapeutics Raises €4m in Seed Funding to Overcome Resistance in Oncology Targeted Therapies | Pharmtech Focus
Advent France Biotechnology (AFB) Appoints Sidonie Fabre as CFO | Pharmtech Focus